Borgerding, Andrea <br/><br/>
Rituximab retherapy in patients with relapsed aggressive B cell and mantle cell lymphoma.  [electronic resource] 

 -  Annals of hematology  Mar 2010 
 - 283-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-0584 
<br/><br/><label>Standard No.: </label>10.1007/s00277-009-0820-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>Female<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Humans<br/>Lymphoma, B-Cell--drug therapy<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Lymphoma, Mantle-Cell--drug therapy<br/>Male<br/>Middle Aged<br/>Remission Induction<br/>Retrospective Studies<br/>Rituximab<br/>Salvage Therapy--methods<br/>Survival Rate<br/>Transplantation, Homologous<br/>Young Adult